SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is soaring on reports of a strategic partnership with Novo Nordisk to distribute obesity drugs, effectively ending their previous legal dispute. The community is actively anticipating a massive short squeeze, with widespread calls to hold shares and discussions of potential GME-like rallies due to high short interest.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending as crude oil prices surge amid escalating Middle East tensions and global supply disruptions, sparking strong community speculation about a massive short squeeze. Investors are actively discussing potential price manipulation and anticipating significant upside movement, drawing comparisons to its past explosive rallies in a volatile energy market.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as the G7 and IEA announced a historic, coordinated release of strategic oil reserves to combat supply shocks from the escalating Iran crisis, while the community debates if this intervention will curb surging prices or if ongoing production cuts and Strait of Hormuz threats suggest further upside.

ProShares Trust - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil (UCO) is trending as escalating geopolitical tensions in the Middle East, particularly around the Strait of Hormuz, fuel fears of significant crude supply disruptions. The community is actively discussing its 2x leveraged performance amidst oil's sharp upward moves and debating potential shorting opportunities if the rally proves unsustainable.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is experiencing a surge following positive Phase 3 data from Roche's giredestrant, a similar oral SERD drug for breast cancer, which has ignited community discussions about OLMA's lead candidate, palazestrant, its multi-billion dollar market potential, and speculation of a potential buyout.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

The departure of a key FDA official, known for a tough stance on gene therapies, is driving significant bullish sentiment and active community discussion around uniQure (QURE), with many anticipating a more favorable regulatory environment for its Huntington's disease treatment and potential for substantial upside.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as escalating Middle East tensions, particularly the effective disruption of the Strait of Hormuz and attacks on critical oil infrastructure, are driving a significant surge in global crude prices. The community is actively debating whether this signals a sustained "physical squeeze" on supply, prompting a broader market repricing of inflation risk and a rotation into energy.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is a top trending topic as investors eagerly await the S&P 500 rebalance announcement, sparking intense community debate over its potential inclusion. Many long-term holders highlight the fintech's fundamental growth and recent insider buying as key confidence indicators despite broader market headwinds.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as escalating geopolitical tensions in the Middle East trigger a significant surge in oil prices, fueling intense community debate about the market's vulnerability and potential broader economic consequences for technology and growth stocks.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics (ZVRA) is trending ahead of its upcoming Q4 earnings, with significant community anticipation for strong revenue and a potential shift to profitability. This is further amplified by the recent appointment of Justin Renz as CFO, whose 'Genzyme Mafia' connections are fueling heightened speculation about a potential acquisition by major pharmaceutical companies like Sanofi or Jazz, eager to integrate ZVRA's rare disease pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


zbettbrcom

Nhà cái ZBETT